Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.01 | 0.7 |
mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |